| AEPCX | FADIX | AEPCX / FADIX | |
| Total Expense Ratio | 1.58 | 1.36 | 116% |
| Annual Report Gross Expense Ratio | 1.58 | 1.36 | 116% |
| Fund Existence | 25 years | 28 years | - |
| Gain YTD | 3.168 | 11.588 | 27% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 141B | 1.83B | 7,692% |
| Annual Yield % from dividends | 2.13 | 1.04 | 205% |
| Returns for 1 year | 6.78 | 8.35 | 81% |
| Returns for 3 years | 14.70 | 26.17 | 56% |
| Returns for 5 years | -7.30 | 1.44 | -508% |
| Returns for 10 years | 38.82 | 64.01 | 61% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PIE | 29.80 | 0.73 | +2.51% |
| Invesco DW Emerging Markets Momt ETF | |||
| NBGX | 28.91 | 0.43 | +1.50% |
| Neuberger Growth ETF | |||
| FAPR | 46.96 | 0.24 | +0.50% |
| FT Vest US Equity Buffer ETF Apr | |||
| KCOP | 22.89 | -0.19 | -0.82% |
| Kurv Copper & Mining Enhanced Income ETF | |||
| HELX | 38.83 | -0.92 | -2.30% |
| Franklin Genomic Advancements ETF | |||